Published on 25 Apr 2024 on Simply Wall St. via Yahoo Finance
MeiraGTx Holdings plc (NASDAQ:MGTX) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The US$317m market-cap company announced a latest loss of US$84m on 31 December 2023 for its most recent financial year result. As path to profitability is the topic on MeiraGTx Holdings' investors mind, we've decided to gauge market sentiment. Below we will provide a high-level summary of the industry analysts’ expectations for the company.
View our latest analysis for MeiraGTx Holdings